IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q4 2025 Holdings

Filed 2026-02-06 | 39 holdings | $313.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Eli Lilly & Co(LLY)COM532457108$33.5M31,13310.7%
AbbVie Inc(ABBV)COM00287Y109$24.7M108,1817.9%
Merck & Co. Inc(MRK)COM58933Y105$20.6M195,7686.6%
Thermo Fisher Scientific Corp(TMO)COM883556102$17.3M29,9155.5%
Neurocrine Biosciences Inc(NBIX)COM64125C109$13.4M94,7964.3%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$12.6M22,3224.0%
Beone Medicines LTD(ONC)SPONSORED ADS07725L102$12.3M40,4323.9%
Bridgebio Pharma Inc(BBIO)COM10806X102$10.8M141,2963.4%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$10.4M22,9843.3%
Boston Scientific Corp(BSX)COM101137107$10.4M108,6823.3%
Stryker Corporation(SYK)COM863667101$9.4M26,8353.0%
CVS Health Corp(CVS)COM126650100$8.5M106,5182.7%
Krystal Biotech, Inc(KRYS)COM501147102$8.3M33,8532.7%
Cencora Inc(COR)COM03073E105$8.0M23,7732.6%
Ionis Pharmaceuticals Inc(IONS)COM462222100$7.3M92,3772.3%
Revolution Medicines Inc(RVMD)COM76155X100$7.2M90,1842.3%
Amgen Inc(AMGN)COM031162100$7.2M21,9032.3%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$7.1M89,6852.3%
Incyte Corp(INCY)COM45337C102$7.0M70,8512.2%
NewAmsterdam Pharma Co NV(NAMS)ORDINARY SHARESN62509109$6.9M197,0362.2%
Alkermes PLC(ALKS)SHSG01767105$6.8M242,4732.2%
iRhythm Technologies Inc(IRTC)COM450056106$6.7M37,5792.1%
Gilead Sciences Inc(GILD)COM375558103$6.2M50,7962.0%
UFP Technologies Inc(UFPT)COM902673102$5.1M22,9861.6%
Insmed Inc(INSM)COM PAR $.01457669307$4.9M27,8731.5%
Cardinal Health Inc(CAH)COM14149Y108$4.8M23,4701.5%
Abivax SA(ABVX)SPONSORED ADS00370M103$4.3M31,5901.4%
Celcuity Inc(CELC)COM15102K100$4.2M41,8311.3%
Disc medicine inc(IRON)COM254604101$3.8M47,9671.2%
Ideaya Biosciences Inc(IDYA)COM45166A102$3.4M97,4381.1%
Universal Health Services Inc(UNH)COM91324P102$3.2M14,6361.0%
Compass Therapeutics Inc(CMPX)COM20454B104$3.1M584,3321.0%
Soleno Therapeutics Inc(SLNO)COM834203309$2.9M62,7350.9%
Arcellx Inc(ACLX)COMMON STOCK03940C100$2.7M41,7170.9%
Dexcom Inc(DXCM)COM NEW252131107$2.6M39,7220.8%
Autolus Therapeutics PLC(AUTL)SPON ADS05280R100$2.3M1,169,6340.7%
Bicara Therapeutics Inc(BCAX)COM055477103$1.9M111,3630.6%
Corbus Pharmaceuticals Holding(CRBP)COM21833P301$873.1K107,2550.3%
Pyxis Oncology Inc(PYXS)COMMON STOCK747324101$709.8K617,2450.2%